Key Points:
1. Deep learning on fundus images forecasts ischemic stroke risk 10 years out with ~70 % sensitivity.
2. Adding clinical data boosts AUROC 5 points versus the Framingham score.
An AI model that inspects high‑resolution fundus photographs can flag people at risk of ischemic stroke up to ten years before their first event. In a study published this week in npj Digital Medicine, the algorithm reached roughly 70 percent sensitivity on an external UK Biobank test set of 12 000 images. Researchers trained the network on more than 85 000 retinal images, focusing on vessel caliber, tortuosity, and microaneurysm patterns. Adding age, sex, blood pressure, and cholesterol pushed AUROC five points higher than the traditional Framingham 10‑year risk score. That incremental lift sounds small but translates into thousands of strokes averted each year when applied population‑wide. Crucially, the camera hardware costs only a few thousand dollars and is already common in optometry clinics, paving the way for point‑of‑care deployment. The UK Biobank summary highlights how routine eye exams could double as cardiovascular screenings. Principal investigator Dr Siegfried Wagner calls the retina “a window into the brain’s microvasculature,” noting that many stroke‑related changes appear first in the eye. Separate work in Australia shows similar promise for heart‑attack prediction, as reported by MedicalXpress, adding momentum to ocular biomarkers as a new vital sign. Because fundus photography is non‑invasive, regulators view the risk profile as low, smoothing the path to CE‑marking in Europe. NHS pilot sites are being selected now, with plans to screen 100 000 patients across England and Wales starting in early 2026. Public‑health officials hope the tool will especially benefit underserved communities that lack MRI or carotid ultrasound. If successful, retinal AI could shift preventive neurology from reactive treatment to proactive surveillance, one snapshot at a time.
Image: PD
©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.